|
|||||
|
|
Michael Burry's management fund, Scion Asset Management, revealed $1.1 billion in put options for Nvidia and Palantir stocks.
13F filings are a snapshot in what coould be a fast-changing portfolio.
Hedge funds often make best on short-term moves and don't necessarily tell you what they think of a stock's long-term value.
Investors are always eager to see what famous and successful investors are doing in the stock market. Certain funds have to make their holdings public, and anyone can read the 13F filings of retail quarterly holdings for large money management funds.
The market was abuzz last week with the news that Michael Burry, who became famous for shorting the stock market during the 2008 mortgage crisis, was betting against Nvidia (NASDAQ: NVDA) and Palantir Technologies (NASDAQ: PLTR). Both stocks fell recently, and the revelation of Burry's position may have contributed to that.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
While it might be giving investors pause, it's not necessarily what people think it is, and the message may be entirely different from a bet against these two top artificial intelligence (AI) stocks.

Image source: Getty Images.
Michael Burry runs Scion Asset Management, a fund with almost $1.4 billion in assets. Funds with more than $100 million in assets are required to report their holdings quarterly; however, these holdings aren't stagnant by the end of each quarter. What you see in a 13F filing is more of a glimpse into what could be a rapidly changing portfolio.
The classic hedge fund employs hundreds of traders and maintains thousands of equity positions that are constantly in flux. These types of funds typically utilize instruments like call and put options to hedge their bets and ensure, as much as possible, gains for investors. Their 13F filings may not always provide a complete picture, as their positions can change frequently.
Then you have some funds, like Berkshire Hathaway, that aim to take long-term positions. Even Berkshire's positions change from quarter to quarter, but not as frequently, and its positions are more telling.
Scion's portfolio is relatively small, and over the past few years, it's had as few as one position and as many as 33, according to quarterly reports. As of the third quarter, it has eight positions, although it only owns four stocks: Molina Healthcare, Lululemon Athletica, SLM, and Bruker.
Its four other holdings are call options in Pfizer and Halliburton, and put options in Nvidia and Palantir.
Puts are options to sell a stock at a locked-in price. They imply that the buyer thinks the price of the stock is going to decline, and the buyer gets to sell at the higher price. However, you don't have to exercise options, and if the price goes the wrong way, the buyer can just let them expire.
Burry's position, again, is a snapshot in time. He might have anticipated some pressure on these expensive stocks, and indeed, both of their prices have come down recently. Big hedge funds often generate profits from slight movements, and with $1.1 billion in put options, exercising these options could yield a substantial amount of money for the fund, depending on various factors, such as the strike price, the extent of the price decline, and when the fund exercises them. It's entirely possible that they've already been exercised.
That doesn't mean Burry thinks the prices will remain low forever or that these stocks aren't good long-term investments. This could simply be a financial move that makes money for a large fund. Burry could just as easily be buying these stocks as I write this, and Scion's fourth-quarter filing could look completely different from the third-quarter filing.
In fact, in comparison with the second-quarter filing, the only position that has remained is Lululemon, which Burry doubled up on in the third quarter. Every other position was sold out, and the other seven positions are new.
It's great to draw inspiration from successful investors like Burry, but remember that this is his day job, and he has different goals from individual investors.
I don't think Burry's message is to reevaluate Nvidia or Palantir from a long-term investment perspective. His message, if there is one to take, looks more like he thinks they've been overvalued, or that there's enough reason to expect them to fall in the near term. He's clearly a contrarian investor, and his strategy will be different from yours.
So I wouldn't follow Burry into his Nvidia and Palantir bets, but I would keep them in mind as part of a broader analysis if you're considering buying either stock today.
Before you buy stock in Nvidia, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $599,784!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,165,716!*
Now, it’s worth noting Stock Advisor’s total average return is 1,035% — a market-crushing outperformance compared to 191% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of November 10, 2025
SLM is an advertising partner of Motley Fool Money. Jennifer Saibil has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway, Bruker, Lululemon Athletica Inc., Nvidia, Palantir Technologies, and Pfizer. The Motley Fool has a disclosure policy.
| 9 min | |
| 24 min | |
| 1 hour | |
| 2 hours | |
| 2 hours | |
| 3 hours | |
| 3 hours | |
| 3 hours | |
| 3 hours | |
| 4 hours | |
| 4 hours | |
| 5 hours | |
| Nov-15 | |
| Nov-15 | |
| Nov-15 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite